Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.55 CHF | -2.17% | -2.87% | -5.15% |
Feb. 16 | BB Biotech's Loss Narrows in FY23; Operating Income Down | MT |
Feb. 14 | BB Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 190M 208M | Sales 2025 * | 101M 110M | Capitalization | 2.27B 2.49B |
---|---|---|---|---|---|
Net income 2024 * | 152M 166M | Net income 2025 * | 72M 78.84M | EV / Sales 2024 * | 13.5 x |
Net Debt 2024 * | 291M 319M | Net Debt 2025 * | 324M 355M | EV / Sales 2025 * | 25.8 x |
P/E ratio 2024 * |
15
x | P/E ratio 2025 * |
13.9
x | Employees | 10 |
Yield 2024 * |
5.67% | Yield 2025 * |
5.79% | Free-Float | 97.24% |
1 day | -2.53% | ||
1 week | -2.87% | ||
Current month | -10.98% | ||
1 month | -10.29% | ||
3 months | -8.15% | ||
6 months | +12.17% | ||
Current year | -5.15% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Koller
CIO | Chief Investment Officer | 54 | 03-12-31 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Meanwell
BRD | Director/Board Member | 67 | 03-12-31 |
Director/Board Member | 63 | 19-12-31 | |
Chairman | 63 | 19-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 40.55 | -2.17% | 59 272 |
24-04-24 | 41.45 | -0.36% | 57,148 |
24-04-23 | 41.6 | +0.97% | 113,601 |
24-04-22 | 41.2 | -0.48% | 63,519 |
24-04-19 | 41.4 | -0.84% | 62,131 |
Delayed Quote Swiss Exchange, April 25, 2024 at 11:31 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.15% | 2.49B | |
+0.80% | 43.84B | |
+4.87% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+5.92% | 25.53B | |
-25.60% | 18.18B | |
-3.65% | 12.29B | |
+25.56% | 12.29B | |
+6.85% | 11.15B |
- Stock Market
- Equities
- BION Stock